Ultragenyx Pharmaceutical, Inc. (RARE)

23.30 -0.61 (-2.55%) USD  |  NASDAQ  |  Apr 10, 16:00
23.08 -0.22 (-0.94%) Pre-Market: 20:00
More

Ultragenyx Pharmaceutical EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for RARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Xencor, Inc. --